-
Innovation Ranking
NewInnovation Ranking – Penta-Ocean Construction Co Ltd
Penta-Ocean Construction Co Ltd (Penta-Ocean) is a civil engineering and general construction company. It offers a range of civil and architectural engineering services for various projects globally. Penta-Ocean offers its services for various projects including the construction of port and harbor, airport, power station, dam and river work, water supply and sewerage, bridge, railway and road and tunnel projects. It also offers construction services for the environmental facility, industrial and logistics, medical, health and welfare, recreational, office, commercial and lodging,...
-
Sector Analysis
NewSingapore Construction Market Size, Trend Analysis by Sector, Competitive Landscape and Forecast to 2028
Singapore Construction Market Report Overview The Singapore construction market size was $25.4 billion in 2023. The market will achieve an AAGR of more than 4% during 2025-2028. Investments in clean energy projects and transport and public housing projects will drive the construction market demand in Singapore. Singapore Construction Market Outlook, 2023-2028 ($ Billion) Buy the Full Report to Know More about the Singapore Construction Market Forecast Download a Free Report Sample The Singapore construction market research report gives a comprehensive...
-
Analyst Opinions
NewPort Construction Project Insights and Analytics (Q1 2024)
Port Construction Projects Market Overview GlobalData is currently tracking a pipeline of port projects with a total value of $497 billion. South-East Asia accounts for the highest share of construction projects. Major markets in the region are investing substantially in port facilities to maximize trade opportunities with their trading partners and support high growth in trade volumes. The port construction projects market research report will offer a detailed analysis of Port construction projects globally. The report also provides details of...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Selinexor in Non-Small Cell Lung Cancer
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Selinexor in Non-Small Cell Lung Cancer report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Selinexor in Non-Small Cell Lung Cancer Drug Details: Selinexor...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Selinexor in Wilms’ Tumor (Nephroblastoma)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Selinexor in Wilms' Tumor (Nephroblastoma) report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Selinexor in Wilms' Tumor (Nephroblastoma) Drug Details: Selinexor (Xpovio, Nexpovio)...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Selinexor in Atypical Teratoid Rhabdoid Tumor
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Selinexor in Atypical Teratoid Rhabdoid Tumor report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Selinexor in Atypical Teratoid Rhabdoid Tumor Drug Details: Selinexor...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Selinexor in Epithelial Ovarian Cancer
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Selinexor in Epithelial Ovarian Cancer report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Selinexor in Epithelial Ovarian Cancer Drug Details: Selinexor (Xpovio, Nexpovio)...
-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model – Selinexor in Waldenstrom Macroglobulinemia (Lymphoplasmacytic Lymphoma)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Selinexor in Waldenstrom Macroglobulinemia (Lymphoplasmacytic Lymphoma) report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Selinexor in Waldenstrom Macroglobulinemia (Lymphoplasmacytic Lymphoma) Drug Details: Selinexor (Xpovio,...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Selinexor in Post-Polycythemia Vera Myelofibrosis (PPV-MF)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Selinexor in Post-Polycythemia Vera Myelofibrosis (PPV-MF) report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Selinexor in Post-Polycythemia Vera Myelofibrosis (PPV-MF) Drug Details: Selinexor...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Selinexor in Post-Essential Thrombocythemia Myelofibrosis (Post-ET MF)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Selinexor in Post-Essential Thrombocythemia Myelofibrosis (Post-ET MF) report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Selinexor in Post-Essential Thrombocythemia Myelofibrosis (Post-ET MF) Drug...